Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absolute, advertising, AE, AEs, attained, balance, bioavailability, bioequivalence, Biotech, call, callable, called, Chief, clarification, classification, commonly, cumulative, Customer, default, depict, discontinue, discontinued, diversity, earliest, efficacy, eleven, encouraging, environment, event, excessive, February, feet, flow, hypersensitivity, inflation, injection, issuer, Janssen, labor, lead, Letter, line, listed, loan, LOI, lost, modified, Nonrefundable, occupancy, past, predominant, Premium, President, principle, protocol, quickly, rash, receipt, redemption, refund, remission, repayable, resolved, retrospective, RI, rituximab, safe, shortening, source, square, Subtopic, sudden, talacotuzumab, taper, top, vest, Vice
Removed:
addressed, agency, answer, bank, combined, conservative, consolidated, costly, criterion, defendant, Del, disclosing, emerging, government, invest, joined, leave, Motion, opportunity, ordered, original, outcome, Petition, preserve, principally, profitability, proposed, recognizing, Relief, spending, sponsored, Stipulation, substantial
Filing tables
Filing exhibits
Related press release
XNCR similar filings
Filing view
External links